Catalent (CTLT)
(Real Time Quote from BATS)
$59.65 USD
+0.24 (0.40%)
Updated Nov 11, 2024 02:48 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
CTLT 59.65 +0.24(0.40%)
Will CTLT be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CTLT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CTLT
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up
Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates
CTLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year?
Catalent Stock Flat Following the Sell Agreement With Ardena
Other News for CTLT
Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Moderna (MRNA) and HCA Healthcare (HCA)
Catalent Inc Reports Q1 Fiscal 2025 Earnings: $1.02 Billion Revenue, $(0.71) EPS
Catalent’s Biologics Underperformance and PCH Stability Lead to Hold Rating
Catalent Inc. Reports Q1 Fiscal 2025 Results
Catalent GAAP EPS of -$0.71, revenue of $1.02B